Skip to news
JQJO
Latest

Kean Returns Amid Disclosure of Treatment for Depression | JQJO

Kean Returns Amid Disclosure of Treatment for Depression

Kean Returns Amid Disclosure of Treatment for Depression

Tap title to read story

0:00 / 0:42

Washington, D.C. Rep. Tom Kean Jr. returned to the U.S. Capitol this week and delivered a floor speech explaining a months-long absence from the House after missing more than 100 votes since March 5; he said doctors treated him during a hospital stay and that the diagnosis was depression.

His disclosure Tuesday prompted responses from leaders and political opponents: Speaker Mike Johnson said he encouraged transparency, President Trump reiterated support, Democrats noted the district's toss-up rating by Cook Political Report, and Kean will face Democrat Rebecca Bennett this fall as campaigns adjust messaging in a competitive seat.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Timeline

  1. 1. March 5: Kean last participated in a recorded House vote before his absence.
  2. 2. April: Kean released a statement saying he was addressing a 'personal medical issue.'
  3. 3. Early June: Speaker Mike Johnson said he had spoken with Kean and was aware of a medical condition.
  4. 4. This week (late June): Kean returned to the Capitol and delivered a floor speech citing hospital treatment for depression.
  5. 5. Fall: Kean is set to run against Democrat Rebecca Bennett in a competitive general election.

Why it matters

Rep. Kean's openness about his mental health could shift conversations around depression. It may encourage more people to seek help. If you're struggling, consider reaching out to a professional. It's okay to ask for support.

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Tech Coalition Pushes Federal Preemption

Tap title to read story

A powerful coalition of federal legislators, executive branch officials, and multinational technology corporations has coalesced around a strategy of "federal preemption," seeking to strip state governments of their authority over generative AI. The coalition argues that the legal frameworks governing these technologies are in a state of flux as generative AI affects every sector of the economy, from healthcare diagnostics to creative industries. The push aims to centralize regulation at the federal level, limiting state‑level oversight of AI development and deployment.

0:00 / 0:32

BOEM Approves Largest U.S. Offshore

Tap title to read story

0:00 / 0:17

Apple’s Intel Era Shaped PC

Tap title to read story

0:00 / 0:12

JQJO

Find your next story

Search JQJO’s current coverage.